Application of Knitting Structure Textiles in Medical Areas

Open access

Abstract

There are many kinds of medical textiles, such as woven textiles, non-woven textiles, braided textiles and knitted textiles. Non-woven medical textiles constitute more than 60% of the total medical textiles used, but are almost disposable ordinary medical textiles. While knitted fabrics forms a small part of the medical textiles, but are greatly applied in high-tech medical textiles, containing artificial blood vessels, hernia patches, cardiac support devices, knitted medical expandable metallic stents and tendon scaffolds. Knitting structures, including weft knitting structure and warp knitting structure. The knitted textiles are popular for their loose structure, greater flexibility, higher porosity, more flexible structure and better forming technology. The present article will introduce some knitting structures and materials applied in the medical textiles in accordance with non-implantable, implantable, extra-corporeal textiles and healthcare and hygiene products.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1] Czajka R. Development of medical textile market. Fibres & Textiles in Eastern Europe 2005. 13(1): p. 3.

  • [2] Momoh F.U. et al. Development and functional characterization of alginate dressing as potential protein delivery system for wound healing. International Journal of Biological Macromolecules 2015. 81: p. 137-150.

  • [3] Turner T. The development of wound management products. Wound: A Compendium of Clinical Research and Practice 1989. 1(3): p. 155-171.

  • [4] Peršin Z. et al. The study of plasma’s modification effects in viscose used as an absorbent for wound-relevant fluids. Carbohydrate Polymers 2013. 97(1): p. 143-151.

  • [5] Angspatt A. et al. Carboxymethylchitosan alginate and tulle gauze wound dressings: a comparative study in the treatment of partial-thickness wounds. Asian Biomedicine 2011. 5(3): p. 413-416.

  • [6] Azad A.K. et al. Chitosan membrane as a woundhealing dressing: Characterization and clinical application. Journal of Biomedical Materials Research Part B-Applied Biomaterials 2004. 69B(2): p. 216-222.

  • [7] Niekraszewicz A. Chitosan medical dressings. Fibres & Textiles in Eastern Europe 2005. 13(6): p. 3.

  • [8] Jayakumar R. et al. Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnology Advances 2011. 29(3): p. 322-337.

  • [9] Muzzarelli R.A.A. Chitins and chitosans for the repair of wounded skin nerve cartilage and bone. Carbohydrate Polymers 2009. 76(2): p. 167-182.

  • [10] Chen C. et al. Bubble template fabrication of chitosan/ poly(vinyl alcohol) sponges for wound dressing applications. International Journal of Biological Macromolecules 2013. 62: p. 188-193.

  • [11] Muzzarelli R.A.A. Biochemical significance of exogenous chitins and chitosans in animals and patients. Carbohydrate Polymers 1993. 20(1): p. 7-16.

  • [12] Liu Y. and H. Hu Compression property and air permeability of weft-knitted spacer fabrics. Journal of the Textile Institute 2011. 102(4): p. 366-372.

  • [13] Anon 3D warp-knitted textiles - fabrics that fit into a frame. Kettenwirk-Praxis 2013. 04: p. 31-32.

  • [14] Yang Y. and H. Hu Spacer fabric-based exuding wound dressing - Part I: Structural design fabrication and property evaluation of spacer fabrics. Textile Research Journal 2016.

  • [15] Yang Y. and H. Hu Spacer fabric-based exuding wound dressing - Part II: Comparison with commercial wound dressings. Textile Research Journal 2016.

  • [16] Liu Y. et al. Impact compressive behavior of warp-knitted spacer fabrics for protective applications. Textile Research Journal 2012. 82(8): p. 773-788.

  • [17] Rajan T.P. G. Ramakrishnan and P. Kandhavadivu Permeability and impact properties of warp-knitted spacer fabrics for protective application. Journal of the Textile Institute 2016. 107(9): p. 1079-1088.

  • [18] Tong S.-f. et al. Exploring use of warp-knitted spacer fabric as a substitute for the absorbent layer for advanced wound dressing. Textile Research Journal 2015. 85(12): p. 1258-1268.

  • [19] Nemeno-Guanzon J.G. et al. Trends in Tissue Engineering for Blood Vessels. Journal of Biomedicine and Biotechnology 2012. 2012: p. 1-14.

  • [20] Yagi T. et al. Preparation of double-raschel knitted silk vascular grafts and evaluation of short-term function in a rat abdominal aorta. Journal of Artificial Organs 2011. 14(2): p. 89-99.

  • [21] Klosterhalfen B. K. Junge and U. Klinge The lightweight and large porous mesh concept for hernia repair. Expert Review of Medical Devices 2005. 2(1): p. 103-117.

  • [22] Klosterhalfen B. et al. Polymers in hernia repair - common polyester vs. polypropylene surgical meshes. Journal of Materials Science 2000. 35(19): p. 4769-4776.

  • [23] Gao K. et al. Anterior Cruciate Ligament Reconstruction With LARS Artificial Ligament: A Multicenter Study With 3- to 5-Year Follow-up. Arthroscopy: The Journal of Arthroscopic & Related Surgery 2010. 26(4): p. 515-523.

  • [24] Cheng C. S. Ren and P. Chen Ligament advanced reinforcement system versus tendon autograft for anterior cruciate ligament reconstruction: a meta-analysis. Orthopedic Journal of China 2016. 24(20): p. 1868-1875.

  • [25] Li B. Y. Wang and C. Qiu Efficacy of LARS artificial ligament versus tibialis anterior allograft for posterior cruciate ligament reconstruction: a comparative study. Orthopedic Journal of China 2016. 24(18): p. 1650-1654.

  • [26] Parchi P.D. et al. Anterior cruciate ligament reconstruction with LARS™ artificial ligament results at a mean follow-up of eight years. International Orthopaedics 2013. 37(8): p. 1567-1574.

  • [27] Dericks Jr G. Ligament advanced reinforcement system anterior cruciate ligament reconstruction. Operative Techniques in Sports Medicine 1995. 3(3): p. 187-205.

  • [28] Hamido F. et al. The use of the LARS artificial ligament to augment a short or undersized ACL hamstrings tendon graft. The Knee 2011. 18(6): p. 373-378.

  • [29] Starling R.C. et al. Sustained Benefits of the CorCap Cardiac Support Device on Left Ventricular Remodeling: Three Year Follow-up Results From the Acorn Clinical Trial. The Annals of Thoracic Surgery 2007. 84(4): p.1236-1242.

  • [30] Konertz W.F. et al. Passive containment and reverse remodeling by a novel textile cardiac support device. Circulation 2001. 104(12): p. I270-I275.

  • [31] Oz M.C. et al. Global surgical experience with the Acorn cardiac support device. The Journal of Thoracic and Cardiovascular Surgery 2003. 126(4): p. 983-991.

  • [32] Zullo M.A. et al. One-Year Follow-up of Tension-free Vaginal Tape (TVT) and Trans-obturator Suburethral Tape from Inside to Outside (TVT-O) for Surgical Treatment of Female Stress Urinary Incontinence: A Prospective Randomised Trial. European Urology 2007. 51(5): p.1376-1384.

  • [33] Gomelsky A. and R.R. Dmochowski Biocompatibility Assessment of Synthetic Sling Materials for Female Stress Urinary Incontinence. The Journal of Urology 2007. 178(4): p. 1171-1181.

  • [34] Madden B.P. S. Datta and N. Charokopos Experience with ultraflex expandable metallic stents in the management of endobronchial pathology. The Annals of Thoracic Surgery 2002. 73(3): p. 938-944.

  • [35] Gonfiotti A. et al. The first tissue-engineered airway transplantation: 5-year follow-up results. The Lancet. 383(9913): p. 238-244.

  • [36] Gaafar A.H. A.Y. Shaaban and M.S. Elhadidi The use of metallic expandable tracheal stents in the management of inoperable malignant tracheal obstruction. European Archives of Oto-Rhino-Laryngology 2012. 269(1): p. 247-253.

  • [37] Sahoo S. et al. Characterization of a novel polymeric scaffold for potential application in tendon/ligament tissue engineering. Tissue Engineering 2006. 12(1): p. 91-99.

Search
Journal information
Impact Factor


IMPACT FACTOR 2018: 0.927
5-year IMPACT FACTOR: 1.016

CiteScore 2018: 1.21

SCImago Journal Rank (SJR) 2018: 0.395
Source Normalized Impact per Paper (SNIP) 2018: 1.044

Cited By
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 898 636 16
PDF Downloads 728 568 15